Modular Medical, Inc.: Form 10-Q for the period ended Mar 31, 2014
Filed with the SEC on May 15, 2014 and accepted by EDGAR at May 14, 2014, 18:05 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-01-01 to 2014-03-31 | $0 | us-gaap:Revenues |
| Revenue | 9 months2013-07-01 to 2014-03-31 | $0 | us-gaap:Revenues |
| Cost of revenue | 3 months2014-01-01 to 2014-03-31 | $0 | us-gaap:CostOfGoodsSold |
| Cost of revenue | 9 months2013-07-01 to 2014-03-31 | $0 | us-gaap:CostOfGoodsSold |
| Gross profit | 3 months2014-01-01 to 2014-03-31 | $0 | us-gaap:GrossProfit |
| Gross profit | 9 months2013-07-01 to 2014-03-31 | $0 | us-gaap:GrossProfit |
| Operating income | 3 months2014-01-01 to 2014-03-31 | −$2.1k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2013-07-01 to 2014-03-31 | −$9.0k | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2014-01-01 to 2014-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2013-07-01 to 2014-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-01-01 to 2014-03-31 | −$5.2k | us-gaap:NetIncomeLoss |
| Net income | 9 months2013-07-01 to 2014-03-31 | −$17.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-01-01 to 2014-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 9 months2013-07-01 to 2014-03-31 | −$0.01 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 9 months2013-07-01 to 2014-03-31 | $0 | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2013-07-01 to 2014-03-31 | $0 | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2014-03-31 | $0 | us-gaap:Cash |
| Total assets | At period end2014-03-31 | $0 | us-gaap:Assets |
| Current liabilities | At period end2014-03-31 | $126.8k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-03-31 | $126.8k | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-03-31 | −$126.8k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001548123-14-000193. Last ingested by Listed: Nov 11, 2026, 02:48 ET. Listed shows no prices and gives no investment advice.